Could fewer zaps do the job? new trial tests low-dose radiation for lymphoma
NCT ID NCT06386315
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a reduced radiation dose (3 treatments) against the standard 12 treatments for people with indolent (slow-growing) non-Hodgkin lymphoma. The goal is to see if the shorter course is safer and still works well at controlling the cancer. About 112 adults with certain types of lymphoma are being enrolled.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOLLICULAR LYMPHOMA, GRADE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Mayo Clinic Health System - Mankato
RECRUITINGMankato, Minnesota, 56001, United States
Contact Email: •••••@•••••
-
Mayo Clinic Health System in Albert Lea
RECRUITINGAlbert Lea, Minnesota, 56007, United States
Contact Email: •••••@•••••
-
Mayo Clinic Health System-Eau Claire Clinic
RECRUITINGEau Claire, Wisconsin, 54701, United States
Contact Email: •••••@•••••
-
Mayo Clinic Health System-Franciscan Healthcare
RECRUITINGLa Crosse, Wisconsin, 54601, United States
Contact Email: •••••@•••••
-
Mayo Clinic in Arizona
RECRUITINGScottsdale, Arizona, 85259, United States
Contact Email: •••••@•••••
-
Mayo Clinic in Florida
RECRUITINGJacksonville, Florida, 32224-9980, United States
Contact Email: •••••@•••••
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Triple-Drug combo wipe out Slow-Growing lymphomas?
- Engineered immune cells take aim at Hard-to-Treat lymphomas
- Can donor immune cells be engineered to fight blood cancer?
- Can a targeted drug boost standard therapy for a rare lymphoma?
- Smartwatches track hidden heart risk in blood cancer patients
- Engineered immune cells get a boost: new combo therapy targets Hard-to-Treat blood cancers